Abstract
Intrathoracic impedance measured by cardiac resynchronization therapy (CRT) varies because several factors other than pulmonary congestion may affect this parameter. Therefore, we hypothesized that changes in intracardiac impedance between the right and left ventricular leads would be more accurate to identify worsening heart failure in patients with CRT. The study enrolled 21 patients with CRT defibrillator (15 males, 70 ± 12 years). During the follow-up period (12 ± 7 months), the subjects experienced 37 fluid index threshold (60 ohm-days) crossing events. These events were divided into two groups whether hospitalization due to worsening heart failure was required (group-H, n = 14) or not (group-NH, n = 23). Based on the intracardiac impedance at the beginning of increasing fluid index (BI) and the crossing of 60 ohm-days (CI), the rate of impedance change (BI–CI/BI) was estimated. Then, the time elapsed from BI to CI (T) was evaluated. We calculated the rate of intracardiac impedance change per day (BI–CI/BI × T) in each group. The rate of intrathoracic impedance change per day was also determined using the same method. The median rate of intracardiac impedance change per day was 0.27 (IQR 0.22–0.54) %/day in group-H, and 0 (IQR 0–0.08) %/day in group-NH with a significant difference (P < 0.0001), whereas the rate of intrathoracic impedance change per day was similar between the two groups. By receiver operating characteristic curve for identification of hospitalization due to worsening heart failure, the best cutoff value of the rate of intracardiac impedance change per day was 0.20%/day (sensitivity 92%, specificity 88%, and AUC 0.98). In contrast, the best cutoff value of the rate of intrathoracic impedance change per day was 0.19%/day (sensitivity 86%, specificity 43%, and AUC 0.68). These results suggest that increased rate of change of decreasing intracardiac impedance measured by CRT is a novel useful predictor for worsening heart failure.
Similar content being viewed by others
References
Gheorghiade M, Vaduganathan M, Fonarow CC, Bonow RO (2013) Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 61:391–403
Sato T, Yamauchi H, Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2015) Serum cholinesterase is an important prognostic factor in chronic heart failure. Heart Vessels 30:204–210
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van derMeer P, Authors/Task Force Members (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group, Multicenter InSync Randomized Clinical Evaluation (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac-resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549
Nabeta T, Inomata T, Iida Y, Ikeda Y, Iwamoto-Ishida M, Ishii S, Naruke T, Mizutani T, Shinagawa H, Koitabashi T, Takeuchi I, Ako J (2016) Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Heart Vessels 31:1109–1116
Kamioka M, Suzuki H, Yamada S, Kamiyama Y, Saitoh S, Takeishi Y (2012) High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation. Int Heart J 53:306–312
Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP (2005) Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112:841–848
Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B, European InSync Sentry Observational Study Investigators (2007) Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 28:1835–1840
Yamada S, Suzuki H, Kamiyama Y, Saitoh S, Takeishi Y (2014) Predictive impact of the decreasing rate of intrathoracic impedance in worsening chronic heart failure. J Interv Card Electrophysiol 40:87–91
Wang L (2007) Key lessons from cases worldwide. Am J Cardiol 99:34G–40G
Stahl C, Beierlein W, Walker T, Straub A, Nagy Z, Knubben K, Greiner TO, Lippert M, Czygan G, Paule S, Schweika O, Kühlkamp V (2007) Intracardiac impedance monitors hemodynamic deterioration in a chronic heart failure pig model. J Cardiovasc Electrophysiol 18:985–990
Maines M, Landolina M, Lunati M, Lonardi G, Pappone A, Proclemer A, Zanotto G, Santini M, Varbaro A, Vimercati M, Valsecchi S, Italian Clinical Service Optivol-CRT Group (2010) Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol 33:64–73
Makee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham Study. N Engl J Med 285:1441–1446
Zile MR, Bennett TD, St. John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118:1433–1441
Binkley PF, Porterfield JG, Porterfield LM, Beau SL, Corbisiero R, Greer GS, Love CJ, Turkel M, Bjorling A, Qu F, Farazi TG (2012) Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients. J Interv Card Electrophysiol 35:197–206
Heist EK, Herre JM, Binkley PF, VanBakel AB, Porterfield JG, Porterfield LM, Qu F, Turkel M, Pavri BB, DEFEAT- PE Study Investigators (2014) Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study). Am J Cardiol 114:1249–1256
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
H.S. belongs to endowed department by St. Jude Medical Japan Inc. and Biotronic Japan Inc. These companies are not associated with the present study. Others do not have COI.
Rights and permissions
About this article
Cite this article
Suzuki, H., Nodera, M., Kamioka, M. et al. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure. Heart Vessels 32, 926–931 (2017). https://doi.org/10.1007/s00380-017-0953-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-017-0953-z